Showing results (1-10 of 261) with videos related to
Sort By:
Pageof 27
International Journal of Clinical Oncology|September 5, 2003
Target molecules in specific immunotherapy against prostate cancerMamoru Harada, Masanori Noguchi, Kyogo ItohOncology Reports|February 3, 2007
Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patientsMamoru Harada, Yuki Ishihara, Kyogo Itoh, et al.Cancer Science|July 5, 2003
Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24+ prostate cancer patientsKazuhiko Kobayashi, Masanori Noguchi, Kyogo Itoh, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Vaccination of cytotoxic T lymphocyte-directed peptides elicited and spread humoral and Th1-type immune responses to prostate-specific antigen protein in a prostate cancer patientMamoru Harada, Satoko Matsueda, Akihisa Yao, et al.International Journal of Oncology|September 6, 2005
Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor typesYoshimi Arima, Satoko Matsueda, Hirohisa Yano, et al.The Prostate|September 2, 2003
Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patientsMamoru Harada, Kazuhiko Kobayashi, Satoko Matsueda, et al.Cancer Immunology, Immunotherapy : CII|November 25, 2003
Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2(+) patients with hormone-refractory prostate cancerSatoko Matsueda, Kazuhiko Kobayashi, Yoichi Nonaka, et al.Oncology Reports|August 4, 2004
Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patientsMamoru Harada, Satoko Matsueda, Akihisa Yao, et al.The Prostate|July 21, 2004
Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)-derived peptides immunogenic in HLA-A24+ prostate cancer patientsRika Ogata, Satoko Matsueda, Akihisa Yao, et al.Cancer Immunology, Immunotherapy : CII|May 16, 2002
A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulationNaoya Hida, Yoshiaki Maeda, Kazuko Katagiri, et al.Pageof 27